Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Merck
Harvard Business School
Boehringer Ingelheim
AstraZeneca

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Litigation Details for SANOFI-AVENTIS U.S. LLC v. MYLAN N v. (D.N.J. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

SANOFI-AVENTIS U.S. LLC v. MYLAN N v. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-10-24
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties BIOCON LTD.; BIOCON RESEARCH LTD.; BIOCON S.A.; BIOCON SDN.BHD; MYLAN GMBH; MYLAN INC.; MYLAN N.V.; MYLAN PHARMACEUTICALS INC.; SANOFI WINTHROP INDUSTRIE; SANOFI-AVENTIS DEUTSCHLAND GMBH; SANOFI-AVENTIS U.S. LLC
Patents 6,235,004; 7,476,652; 7,713,930; 7,918,833; 8,512,297; 8,556,864; 8,603,044; 8,679,069; 8,992,486; 9,011,391; 9,233,211; 9,408,979; 9,526,844; 9,533,105; 9,561,331; 9,604,008; 9,604,009; 9,610,409; 9,623,189
Attorneys ARNOLD B. CALMANN; CHRISTINE INTROMASSO GANNON; JEFFREY S. SOOS; KATELYN O'REILLY; KATHERINE ANN ESCANLAR; LIZA M. WALSH; WILLIAM T. WALSH , JR
Link to Docket External link to docket
Small Molecule Drugs cited in SANOFI-AVENTIS U.S. LLC v. MYLAN N v.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for SANOFI-AVENTIS U.S. LLC v. MYLAN N v. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 7,476,652 (“the ’652 patent”), 7,713,930 (“the ’930 patent”), 7,918,833 (“… Review as to Patent No. 7,476,652 filed on June 5, 2017 with the United States Patent and Trademark… (Infringement of U.S. Patent No. 7,476,652) 101. Plaintiffs repeat and re-allege…Declaratory Judgment of Infringement of U.S. Patent No. 7,476,652) 173. Plaintiffs repeat and …Sheet, # 4 AO120 Patent Form (I of IV), # 5 AO120 Patent Form (II of IV), # 6 AO120 Patent Form (III of IV External link to document
0000-00-00 319 Plaintiffs own U.S. Patent Nos. 7,476,652 and 7,713,930 (the “formulation patents”) and U.S. Patent Nos. 8,603,044…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…the ʼ008 patent has no parent application in common with the device patents in the U.S. patent system.…between the ʼ008 patent and the four device patents rests on the fact that all five patents assert a priority…this patent infringement action, the parties seek construction of claim terms in six U.S. Patents. For External link to document
0000-00-00 440 invalidity of U.S. Patent Nos. 7,476,652 and 7,713,930 (together, the “formulation patents.”) In short, …invalidity due to obviousness as to the formulation patents. There is no dispute that, previously, Defendants…filed petitions for Inter Partes Review of these patents and that, in December of 2018, the PTAB issued…Decisions which found that both formulation patents were invalid due to obviousness. Appeals of the…proof. Sanofi points out that the presumption of patent validity did not apply before the PTAB, and that External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
McKesson
Dow
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.